Rare diseases
Investigational molecules
Locations
Back to Italy987 clinical trials in Candiolo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B
ItalyStudy Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence
ItalyStudy on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer
ItalyStudy of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
ItalyStudy of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
ItalyStudy on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome
ItalyStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
ItalyStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
ItalyStudy on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer
ItalyStudy on the Safety and Antitumor Effects of Vepdegestrant and Abemaciclib in Adults with ER+ Advanced or Metastatic Breast Cancer
ItalyStudy of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma
ItalyStudy on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on blood cancers including innovative treatments for myelodysplastic syndromes, follicular lymphoma, and chronic myelomonocytic leukemia. Studies evaluate novel drug combinations and maintenance therapies to improve patient outcomes.
Trials investigate targeted therapies and immunotherapy approaches for better disease management.
Comprehensive research on lung cancer, breast cancer, and colorectal cancer. Studies explore combination therapies involving immunotherapy, targeted agents, and conventional treatments to enhance treatment efficacy.
Focus on personalized medicine approaches and biomarker-driven treatment selection.
Dedicated research into sarcomas, head and neck cancers, and other rare malignancies. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Emphasis on developing effective treatments for cancers with limited therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
